Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11580966rdf:typepubmed:Citationlld:pubmed
pubmed-article:11580966lifeskim:mentionsumls-concept:C0014507lld:lifeskim
pubmed-article:11580966lifeskim:mentionsumls-concept:C0011860lld:lifeskim
pubmed-article:11580966lifeskim:mentionsumls-concept:C0039260lld:lifeskim
pubmed-article:11580966pubmed:dateCreated2001-10-2lld:pubmed
pubmed-article:11580966pubmed:abstractTextIn the face of the growing worldwide prevalence of type 2 diabetes, effective methods of preventing further increases in prevalence are needed. In this paper, we review the community-based epidemiologic studies of diabetes in Taiwan published during the last decade, and look at the effectiveness of a two-stage screening protocol for identifying subjects at risk for progression to type 2 diabetes. The results of these studies indicate that the age-adjusted prevalence rate of undiagnosed diabetes in Taiwan is stable, at around 4.0%, while the annual incidence rate is about 1.8%. The results of several studies strongly suggest that a two-step screening strategy, in which only subjects with a fasting plasma glucose level of 5.6-7.8 mmol/l receive the oral glucose tolerance test, may be an effective means of identifying diabetics and persons at high risk for progression to type 2 diabetes and, ultimately, slowing the increase in the prevalence of this disease.lld:pubmed
pubmed-article:11580966pubmed:languageenglld:pubmed
pubmed-article:11580966pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11580966pubmed:citationSubsetIMlld:pubmed
pubmed-article:11580966pubmed:statusMEDLINElld:pubmed
pubmed-article:11580966pubmed:monthNovlld:pubmed
pubmed-article:11580966pubmed:issn0168-8227lld:pubmed
pubmed-article:11580966pubmed:authorpubmed-author:MAC CCClld:pubmed
pubmed-article:11580966pubmed:authorpubmed-author:TsaiS TSTlld:pubmed
pubmed-article:11580966pubmed:authorpubmed-author:ChorSSlld:pubmed
pubmed-article:11580966pubmed:issnTypePrintlld:pubmed
pubmed-article:11580966pubmed:volume54 Suppl 1lld:pubmed
pubmed-article:11580966pubmed:ownerNLMlld:pubmed
pubmed-article:11580966pubmed:authorsCompleteYlld:pubmed
pubmed-article:11580966pubmed:paginationS29-35lld:pubmed
pubmed-article:11580966pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:11580966pubmed:meshHeadingpubmed-meshheading:11580966...lld:pubmed
pubmed-article:11580966pubmed:meshHeadingpubmed-meshheading:11580966...lld:pubmed
pubmed-article:11580966pubmed:meshHeadingpubmed-meshheading:11580966...lld:pubmed
pubmed-article:11580966pubmed:meshHeadingpubmed-meshheading:11580966...lld:pubmed
pubmed-article:11580966pubmed:meshHeadingpubmed-meshheading:11580966...lld:pubmed
pubmed-article:11580966pubmed:meshHeadingpubmed-meshheading:11580966...lld:pubmed
pubmed-article:11580966pubmed:meshHeadingpubmed-meshheading:11580966...lld:pubmed
pubmed-article:11580966pubmed:year2001lld:pubmed
pubmed-article:11580966pubmed:articleTitleEpidemiology of type 2 diabetes in Taiwan.lld:pubmed
pubmed-article:11580966pubmed:affiliationCommunity Medicine Research Center and Institute of Public Health, National Yang-Ming University, Shih-Pai, Taipei 112, Taiwan, ROC. pschou@ym.edu.twlld:pubmed
pubmed-article:11580966pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11580966pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11580966lld:pubmed